Surprisingly, reconstituted 786-O-VHL ccRCC cells were fully resistant against zafirlukast-induced cell death compared to 786-O-EV ccRCC cells (Figure 1E), which undergo cell death to the same extent as wild-type 786-O ccRCC cells. This evidence concerns the gene VHL and nonpapillary renal cell carcinoma.